210. Exits: $10.8B Exit to Merck with Prometheus Biosciences CEO Mark McKenna

Subscribe & Listen Everywhere:

The State of MedTech Hosted By Omar M. Khateeb

210. Exits: $10.8B Exit to Merck with Prometheus Biosciences CEO Mark McKenna

00:00 / 00:25:39

00:00 Introduction and Welcome

00:32 Guest Introduction: Mark McKenna

00:42 The Prometheus Acquisition by Merck

01:01 Mark’s Career Journey and Decision to Join Prometheus

04:55 Challenges and Strategies in the First Year

06:48 Key Inflection Points and Fundraising

08:58 Building a Competitive and Sustainable Company

13:32 Navigating Market Challenges and Competition

19:33 Reflections and Leadership Insights

21:32 Future of Biotech and Industry Concerns

24:42 Conclusion and Farewell

For limited time only – Get the Medical Sales Network Effects Program for 60% off https://salesnetworkeffectsprogram.mykajabi.com/offers/FV2MG8sK?coupon_code=PODCAST2024

Follow The State of MedTech on:

Follow Omar M. Khateeb on

I’m Omar Khateeb

I’m Omar Khateeb. I help medtech sales people succeed by learning and leveraging skills that I developed initially for myself, to sell in medtech as a salesperson and sales leader.

I’m not a guru and I don’t have a grand theory. Instead there’s vision backed by experience and research. I know how to do it because I’ve done it, so I can show you how.